Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1997-10-14
pubmed:abstractText
If complement (C) activation is prevented or the host is C depleted, discordant vascularized xenografts undergo delayed xenograft rejection (DXR), characterized by graft infiltration by macrophages (MO) and natural killer (NK) cells, endothelial cell activation, and widespread fibrin deposition. Given a lack of effect of T cell-directed therapies on development of DXR, we evaluated two novel agents, 15-deoxyspergualin (DSG) and leflunomide (LEF), with reported anti-B-cell and/or anti-MO actions.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Anti-Idiotypic, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CCL2, http://linkedlifedata.com/resource/pubmed/chemical/Chemokines, http://linkedlifedata.com/resource/pubmed/chemical/Complement System Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Guanidines, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin M, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Isoxazoles, http://linkedlifedata.com/resource/pubmed/chemical/Lectins, http://linkedlifedata.com/resource/pubmed/chemical/anti-IgM, http://linkedlifedata.com/resource/pubmed/chemical/gusperimus, http://linkedlifedata.com/resource/pubmed/chemical/leflunomide
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0041-1337
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
64
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
696-704
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9311705-Animals, pubmed-meshheading:9311705-Antibodies, Anti-Idiotypic, pubmed-meshheading:9311705-Antibodies, Monoclonal, pubmed-meshheading:9311705-Antibody Formation, pubmed-meshheading:9311705-B-Lymphocytes, pubmed-meshheading:9311705-Chemokine CCL2, pubmed-meshheading:9311705-Chemokines, pubmed-meshheading:9311705-Complement System Proteins, pubmed-meshheading:9311705-Graft Rejection, pubmed-meshheading:9311705-Graft Survival, pubmed-meshheading:9311705-Guanidines, pubmed-meshheading:9311705-Guinea Pigs, pubmed-meshheading:9311705-Heart Transplantation, pubmed-meshheading:9311705-Immunoglobulin M, pubmed-meshheading:9311705-Immunosuppressive Agents, pubmed-meshheading:9311705-Isoxazoles, pubmed-meshheading:9311705-Lectins, pubmed-meshheading:9311705-Macrophage Activation, pubmed-meshheading:9311705-Macrophages, pubmed-meshheading:9311705-Male, pubmed-meshheading:9311705-Rats, pubmed-meshheading:9311705-Rats, Inbred BN, pubmed-meshheading:9311705-Rats, Inbred Lew, pubmed-meshheading:9311705-Rats, Sprague-Dawley, pubmed-meshheading:9311705-Transplantation, Heterologous, pubmed-meshheading:9311705-Transplantation, Homologous
pubmed:year
1997
pubmed:articleTitle
Effects of leflunomide and deoxyspergualin in the guinea pig-->rat cardiac model of delayed xenograft rejection: suppression of B cell and C-C chemokine responses but not induction of macrophage lectin.
pubmed:affiliation
Sandoz Center for Immunobiology and Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't